MYSTI S BLIZZARD
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family VINELAND, NJ NPI 1982117339
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family NJ Incyte Corporation All categories
General Payments — all program years on this page
$3,363.07
- Category: General Payments
- Program years: PY2021–2024
- Record count: 197
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,133.65 across 63 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,068.65 | 62 |
| Education | $65.00 | 1 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Incyte Corporation | $111.60 | 4 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $102.45 | 5 |
| PFIZER INC. | $91.13 | 5 |
| E.R. Squibb & Sons, L.L.C. | $80.82 | 5 |
| EISAI INC. | $66.50 | 4 |
| GlaxoSmithKline, LLC. | $64.40 | 4 |
| ARRAY BIOPHARMA INC | $58.82 | 4 |
| Genentech USA, Inc. | $51.35 | 3 |
| Celgene Corporation | $49.59 | 3 |
| Lilly USA, LLC | $37.18 | 2 |
| Stemline Therapeutics Inc. | $34.34 | 2 |
| Acerta Pharma LLC | $33.27 | 2 |
| SOBI, INC | $32.19 | 2 |
| Karyopharm Therapeutics Inc. | $31.39 | 1 |
| ABBVIE INC. | $30.10 | 2 |
| ACCORD HEALTHCARE, INC. | $21.35 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $21.13 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $19.50 | 1 |
| Merck Sharp & Dohme Corporation | $19.04 | 1 |
| Agios Pharmaceuticals, Inc. | $18.86 | 1 |
| Deciphera Pharmaceuticals Inc. | $18.41 | 1 |
| Geron Corporation | $17.56 | 1 |
| SERVIER PHARMACEUTICALS LLC | $16.95 | 1 |
| GENZYME CORPORATION | $15.80 | 1 |
| Genmab U.S., Inc. | $15.74 | 1 |
| Janssen Biotech, Inc. | $15.52 | 1 |
| Astellas Pharma US Inc | $15.19 | 1 |
| PUMA BIOTECHNOLOGY, INC. | $15.11 | 1 |
| Daiichi Sankyo Inc. | $15.00 | 1 |
| Rigel Pharmaceuticals, Inc. | $13.36 | 1 |
By program year
Records — PY2024 (63)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.